Navigation Links
Lead-'scrubbing' drug may also improve muscle function in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

Led by Amit Bhattacharya, PhD, the UC team found that children treated with succimer (SUX-sim-er) chelation therapy showed a 19 percent improvement in their ability to perform moving tasks—such as crossing an obstacle or walking—than those who did not receive treatment.

Chelation (ke-LAY-shun) is a technique, nicknamed “scrubbing,?in which a drug is administered to seek out and bind to poisonous heavy metals, such as lead or mercury, in the bloodstream. The compound resulting from this binding is then excreted in the urine, essentially cleaning out the dangerous metals.

Succimer (Chermet) is an oral chelating drug approved by the Food and Drug Administration to treat children with extremely elevated blood lead levels (44 to 69 micrograms per deciliter).

The UC team has found that succimer chelation therapy improved static balance by 6 percent.

“Lead exposure is a very serious issue,?says Bhattacharya, professor of environmental health and lead author of the study, “and it’s important to identify early signs of neuromotor (muscle-function) exposure effects—such as impaired postural balance or locomotion—before permanent damage occurs. Our research may help develop control strategies for minimizing exposure to lead at an earlier stage.?

The team reports its findings in the May 2007 edition of the journal Neurotoxicology. This is the first study to report that succimer chelation therapy can produce beneficial effects on postural balance and movement in lead-exposed children.

Previous research has shown that succimer chelation therapy can reduce lead levels in the blood, but few scientists have investigated whether it can improve neuromotor abilities in this at-risk population.

Bhattacharya and his team wanted to know if succimer chelation therapy could eliminate or minimize lead-associated muscle-function impairments in children exposed to high levels of lead early in life.

The team identified about 160 Cincinnati children with elevated blood lead levels enrolled in the local arm of a randomized, placebo-controlled clinical trial conducted nationally by the Centers for Disease Control and Prevention and the National Institute of Environmental Health Sciences (NIEHS). Postural balance and gait tests were performed only after each child—then 5 years old—had completed the succimer or placebo therapy.

Tests were designed to eliminate or challenge factors that help maintain postural balance, such as eyesight and visual context.

“Our statistical analysis revealed that subjects who received succimer therapy showed a significant improvement in balance and movement compared to the non-therapy group,?says Bhattacharya. “This new data—combined with our previous research—leads us to believe that succimer therapy may also result in reduced injuries among this at-risk population.?

In the October 2006 issue of the Journal of Adolescent Health, Bhattacharya’s team reported that teenagers who experienced high blood lead levels during childhood appear to suffer more accidental injuries than those who had lower lead exposure.

He says further research is needed to determine if succimer therapy can minimize long-term negative effects of lead on balance and movement.

According to the most recent U.S. National Health and Nutrition Examination Survey, more than 434,000 children between the ages of 1 and 5 have elevated blood lead levels. Lead is known to be associated with decreased intellectual capabilities and balance disorders among infants, children and teens.
'"/>

Source:University of Cincinnati


Related biology news :

1. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
2. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
3. Vascular structure and function improve with diet and exercise
4. Scientists discuss improved biopesticides for locust control in West Africa
5. Product improves peptide identification for proteomics research
6. Engineers improve plastics potential for use in implants by linking it to biological material
7. U. Iowa researchers improve Huntingtons disease symptoms in mice
8. Stem cell treatment improves mobility after spinal cord injury
9. Fragile US vaccine system needs improvement despite dramatic gains in health over past century
10. Monkeying around to improve organ transplantation
11. Research suggests fitness of Florida panthers improved by limited breeding with Texas animals

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: